scispace - formally typeset
V

V. Wee Yong

Researcher at University of Calgary

Publications -  276
Citations -  21024

V. Wee Yong is an academic researcher from University of Calgary. The author has contributed to research in topics: Multiple sclerosis & Microglia. The author has an hindex of 73, co-authored 233 publications receiving 17556 citations. Previous affiliations of V. Wee Yong include Allen Institute for Brain Science & Foothills Medical Centre.

Papers
More filters
Journal ArticleDOI

Matrix metalloproteinases in intracerebral hemorrhage

TL;DR: The experimental data support the use of pharmacologic anti-matrix metalloproteinases strategies in the acute periods following intracerebral hemorrhage to alleviate injury.
Journal ArticleDOI

Monocytes increase human cardiac myofibroblast-mediated extracellular matrix remodeling through TGF-β1

TL;DR: Direct cell-cell interaction between monocytes and cardiac myofibroblasts stimulates TGF-β-mediated myofIBroblast activity and increases remodeling of local matrix in a three-dimensional ECM microenvironment, suggesting inflammation as a potential driver of cardiac fibrosis.
Journal ArticleDOI

A quantitative analysis of suspected environmental causes of MS.

TL;DR: A very significant negative correlation between MS prevalence and available ultraviolet (UV) radiation is reported and the available ultraviolet radiation is a significant environmental factor, moreso than all the other factors examined.
Journal ArticleDOI

Regenerative Capacity of Macrophages for Remyelination

TL;DR: This review will discuss the beneficial roles of macrophages/microglia in remyelination and discuss therapeutic strategies to obtain the optimal regenerative macrophage phenotype for enhanced remYelination.
Journal ArticleDOI

Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome.

TL;DR: Modification of the microbiome, the use of probiotics, fecal microbiota transplantation, supplementation with bile acids and intestinal barrier enhancers are all promising candidates and hopefully, pre-clinical studies and clinical trials will soon yield significant results.